In summary, this research identifies OSGIN2 as a possible gene associated with gastric cancer progression through a combination of bioinformatics analysis and cellular experiments, and expects it to be a promising therapeutic target for improving the therapeutic efficacy and prognosis of gastric cancer. This evidence concerns the gene OSGIN2 and gastric cancer.